| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.44e-05 | 188 | 8 | 3 | GO:0005201 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.44e-04 | 46 | 8 | 2 | GO:0030020 | |
| GeneOntologyMolecularFunction | heparin binding | 2.48e-03 | 192 | 8 | 2 | GO:0008201 | |
| GeneOntologyMolecularFunction | structural molecule activity | 4.19e-03 | 891 | 8 | 3 | GO:0005198 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 4.76e-03 | 268 | 8 | 2 | GO:0005539 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 5.05e-03 | 276 | 8 | 2 | GO:0003730 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 6.85e-03 | 323 | 8 | 2 | GO:1901681 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 2.66e-06 | 76 | 8 | 3 | GO:0030199 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 2.77e-04 | 957 | 8 | 4 | GO:0097435 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 3.17e-04 | 377 | 8 | 3 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 3.19e-04 | 378 | 8 | 3 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 3.22e-04 | 379 | 8 | 3 | GO:0045229 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 8.17e-04 | 1269 | 8 | 4 | GO:0009887 | |
| GeneOntologyBiologicalProcess | sensory perception of sound | 2.47e-03 | 198 | 8 | 2 | GO:0007605 | |
| GeneOntologyBiologicalProcess | mRNA destabilization | 2.67e-03 | 206 | 8 | 2 | GO:0061157 | |
| GeneOntologyBiologicalProcess | RNA destabilization | 2.80e-03 | 211 | 8 | 2 | GO:0050779 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA catabolic process | 2.80e-03 | 211 | 8 | 2 | GO:0061014 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 3.55e-03 | 238 | 8 | 2 | GO:0050954 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 4.18e-03 | 259 | 8 | 2 | GO:1903313 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 1.28e-06 | 5 | 8 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 8.44e-06 | 12 | 8 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 8.44e-06 | 12 | 8 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 2.68e-05 | 21 | 8 | 2 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen trimer | 4.83e-04 | 88 | 8 | 2 | GO:0005581 | |
| GeneOntologyCellularComponent | catalytic step 2 spliceosome | 5.86e-04 | 97 | 8 | 2 | GO:0071013 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 8.25e-04 | 530 | 8 | 3 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 1.53e-03 | 656 | 8 | 3 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 1.54e-03 | 658 | 8 | 3 | GO:0030312 | |
| GeneOntologyCellularComponent | spliceosomal complex | 2.83e-03 | 215 | 8 | 2 | GO:0005681 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 6.61e-03 | 332 | 8 | 2 | GO:0005788 | |
| MousePheno | abnormal articular cartilage morphology | 1.95e-05 | 14 | 7 | 2 | MP:0006433 | |
| MousePheno | abnormal tectorial membrane morphology | 1.06e-04 | 32 | 7 | 2 | MP:0003149 | |
| MousePheno | abnormal hyaline cartilage morphology | 2.20e-04 | 46 | 7 | 2 | MP:0006429 | |
| MousePheno | abnormal synovial joint morphology | 1.59e-03 | 124 | 7 | 2 | MP:0030804 | |
| MousePheno | abnormal auditory brainstem response | 2.15e-03 | 576 | 7 | 3 | MP:0004738 | |
| MousePheno | abnormal hearing electrophysiology | 2.35e-03 | 594 | 7 | 3 | MP:0006335 | |
| MousePheno | abnormal hearing physiology | 2.95e-03 | 643 | 7 | 3 | MP:0001963 | |
| MousePheno | abnormal ear physiology | 3.52e-03 | 684 | 7 | 3 | MP:0003878 | |
| MousePheno | impaired hearing | 5.05e-03 | 223 | 7 | 2 | MP:0006325 | |
| MousePheno | abnormal cochlear labyrinth morphology | 5.59e-03 | 235 | 7 | 2 | MP:0004426 | |
| MousePheno | abnormal scala media morphology | 5.59e-03 | 235 | 7 | 2 | MP:0003169 | |
| MousePheno | increased or absent threshold for auditory brainstem response | 5.64e-03 | 236 | 7 | 2 | MP:0011967 | |
| MousePheno | abnormal cochlea morphology | 6.21e-03 | 248 | 7 | 2 | MP:0000031 | |
| MousePheno | abnormal membranous labyrinth morphology | 6.91e-03 | 262 | 7 | 2 | MP:0000035 | |
| MousePheno | hearing/vestibular/ear phenotype | 7.77e-03 | 905 | 7 | 3 | MP:0005377 | |
| MousePheno | increased startle reflex | 7.91e-03 | 281 | 7 | 2 | MP:0001488 | |
| MousePheno | abnormal inner ear morphology | 9.15e-03 | 303 | 7 | 2 | MP:0000026 | |
| MousePheno | abnormal cartilage morphology | 1.12e-02 | 336 | 7 | 2 | MP:0000163 | |
| MousePheno | abnormal joint morphology | 1.54e-02 | 397 | 7 | 2 | MP:0002932 | |
| Domain | HnRNP_R/Q_splicing_fac | 1.60e-06 | 5 | 8 | 2 | IPR006535 | |
| Domain | Fib_collagen_C | 8.81e-06 | 11 | 8 | 2 | IPR000885 | |
| Domain | COLFI | 8.81e-06 | 11 | 8 | 2 | SM00038 | |
| Domain | NC1_FIB | 8.81e-06 | 11 | 8 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 8.81e-06 | 11 | 8 | 2 | PD002078 | |
| Domain | COLFI | 8.81e-06 | 11 | 8 | 2 | PF01410 | |
| Domain | TSPN | 4.04e-05 | 23 | 8 | 2 | SM00210 | |
| Domain | Laminin_G_2 | 1.24e-04 | 40 | 8 | 2 | PF02210 | |
| Domain | LamG | 1.51e-04 | 44 | 8 | 2 | SM00282 | |
| Domain | Laminin_G | 2.62e-04 | 58 | 8 | 2 | IPR001791 | |
| Domain | Collagen | 5.63e-04 | 85 | 8 | 2 | IPR008160 | |
| Domain | Collagen | 5.63e-04 | 85 | 8 | 2 | PF01391 | |
| Domain | - | 7.03e-04 | 95 | 8 | 2 | 2.60.120.200 | |
| Domain | RRM_1 | 3.31e-03 | 208 | 8 | 2 | PF00076 | |
| Domain | RRM | 3.59e-03 | 217 | 8 | 2 | SM00360 | |
| Domain | ConA-like_dom | 3.66e-03 | 219 | 8 | 2 | IPR013320 | |
| Domain | RRM_dom | 3.92e-03 | 227 | 8 | 2 | IPR000504 | |
| Domain | RRM | 4.03e-03 | 230 | 8 | 2 | PS50102 | |
| Domain | - | 4.52e-03 | 244 | 8 | 2 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 5.04e-03 | 258 | 8 | 2 | IPR012677 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.60e-05 | 19 | 7 | 2 | MM15512 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 9.13e-05 | 30 | 7 | 2 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 9.13e-05 | 30 | 7 | 2 | MM15517 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.04e-04 | 32 | 7 | 2 | MM14924 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.72e-04 | 41 | 7 | 2 | MM15538 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.72e-04 | 41 | 7 | 2 | M27778 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.98e-04 | 44 | 7 | 2 | M27812 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 2.16e-04 | 46 | 7 | 2 | M198 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.56e-04 | 50 | 7 | 2 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.88e-04 | 53 | 7 | 2 | MM14566 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.13e-04 | 300 | 7 | 3 | M610 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.57e-04 | 59 | 7 | 2 | M27218 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.81e-04 | 61 | 7 | 2 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.81e-04 | 61 | 7 | 2 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.20e-04 | 64 | 7 | 2 | M26953 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 4.47e-04 | 66 | 7 | 2 | M18 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 4.60e-04 | 67 | 7 | 2 | MM15345 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 4.60e-04 | 67 | 7 | 2 | M26999 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 5.61e-04 | 74 | 7 | 2 | M160 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 5.92e-04 | 76 | 7 | 2 | M27219 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 5.92e-04 | 76 | 7 | 2 | MM14573 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 6.39e-04 | 79 | 7 | 2 | M27643 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 7.23e-04 | 84 | 7 | 2 | M7098 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 8.29e-04 | 90 | 7 | 2 | M631 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.33e-03 | 114 | 7 | 2 | MM14571 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.99e-03 | 140 | 7 | 2 | M587 | |
| Pathway | WP_FOCAL_ADHESION | 3.52e-03 | 187 | 7 | 2 | MM15913 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.97e-03 | 199 | 7 | 2 | M7253 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.59e-03 | 258 | 7 | 2 | MM14572 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 8.95e-03 | 302 | 7 | 2 | M39719 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 1.04e-02 | 326 | 7 | 2 | MM15917 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.67e-02 | 418 | 7 | 2 | MM15587 | |
| Pathway | WP_MRNA_PROCESSING | 1.93e-02 | 451 | 7 | 2 | MM15946 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.63e-02 | 532 | 7 | 2 | M27870 | |
| Pubmed | 1.39e-07 | 3 | 8 | 2 | 34009784 | ||
| Pubmed | Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS. | 1.39e-07 | 3 | 8 | 2 | 30755280 | |
| Pubmed | 1.39e-07 | 3 | 8 | 2 | 36553626 | ||
| Pubmed | SMN interacts with a novel family of hnRNP and spliceosomal proteins. | 2.78e-07 | 4 | 8 | 2 | 11574476 | |
| Pubmed | Collagen XI chain misassembly in cartilage of the chondrodysplasia (cho) mouse. | 2.78e-07 | 4 | 8 | 2 | 17683922 | |
| Pubmed | 2.78e-07 | 4 | 8 | 2 | 23624467 | ||
| Pubmed | 2.78e-07 | 4 | 8 | 2 | 11773003 | ||
| Pubmed | 6.94e-07 | 6 | 8 | 2 | 21467034 | ||
| Pubmed | 6.94e-07 | 6 | 8 | 2 | 10722718 | ||
| Pubmed | Developmental pattern of expression of the mouse alpha 1 (XI) collagen gene (Col11a1). | 6.94e-07 | 6 | 8 | 2 | 8563024 | |
| Pubmed | 6.94e-07 | 6 | 8 | 2 | 17876790 | ||
| Pubmed | 1.30e-06 | 8 | 8 | 2 | 19808671 | ||
| Pubmed | The pro-alpha2(XI) collagen gene is expressed in odontoblasts. | 1.30e-06 | 8 | 8 | 2 | 20059976 | |
| Pubmed | 1.30e-06 | 8 | 8 | 2 | 12183049 | ||
| Pubmed | The atypical homeodomain transcription factor Mohawk controls tendon morphogenesis. | 2.54e-06 | 11 | 8 | 2 | 20696843 | |
| Pubmed | 2.54e-06 | 11 | 8 | 2 | 10734137 | ||
| Pubmed | RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. | 2.54e-06 | 11 | 8 | 2 | 37142680 | |
| Pubmed | 3.05e-06 | 12 | 8 | 2 | 16236758 | ||
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 4.85e-06 | 15 | 8 | 2 | 9832566 | |
| Pubmed | Maturational disturbance of chondrocytes in Cbfa1-deficient mice. | 6.29e-06 | 17 | 8 | 2 | 10213384 | |
| Pubmed | 6.29e-06 | 17 | 8 | 2 | 12388589 | ||
| Pubmed | 1.17e-05 | 23 | 8 | 2 | 8799160 | ||
| Pubmed | 1.39e-05 | 25 | 8 | 2 | 19180518 | ||
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 1.62e-05 | 27 | 8 | 2 | 12192060 | |
| Pubmed | 2.91e-05 | 36 | 8 | 2 | 17289661 | ||
| Pubmed | Identification of DeltaNp63alpha protein interactions by mass spectrometry. | 5.19e-05 | 48 | 8 | 2 | 20085233 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 8.69e-05 | 62 | 8 | 2 | 28344315 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.10e-04 | 444 | 8 | 3 | 34795231 | |
| Pubmed | 1.11e-04 | 70 | 8 | 2 | 20301607 | ||
| Pubmed | 1.45e-04 | 80 | 8 | 2 | 35803934 | ||
| Pubmed | 1.45e-04 | 80 | 8 | 2 | 11991638 | ||
| Pubmed | 1.75e-04 | 88 | 8 | 2 | 26318153 | ||
| Pubmed | DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation. | 1.79e-04 | 89 | 8 | 2 | 22446626 | |
| Pubmed | 1.84e-04 | 90 | 8 | 2 | 23151878 | ||
| Pubmed | 1.84e-04 | 90 | 8 | 2 | 33087562 | ||
| Pubmed | 1.84e-04 | 90 | 8 | 2 | 31280863 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 2.13e-04 | 97 | 8 | 2 | 27559042 | |
| Interaction | ALG13 interactions | 3.99e-05 | 183 | 8 | 3 | int:ALG13 | |
| Interaction | RNF125 interactions | 1.88e-04 | 53 | 8 | 2 | int:RNF125 | |
| Interaction | ZNF169 interactions | 1.95e-04 | 54 | 8 | 2 | int:ZNF169 | |
| Interaction | PAIP2 interactions | 2.66e-04 | 63 | 8 | 2 | int:PAIP2 | |
| Interaction | HNRNPA0 interactions | 2.70e-04 | 349 | 8 | 3 | int:HNRNPA0 | |
| Interaction | WDR77 interactions | 2.99e-04 | 361 | 8 | 3 | int:WDR77 | |
| Interaction | MIR138-1 interactions | 3.10e-04 | 68 | 8 | 2 | int:MIR138-1 | |
| Interaction | MIR9-3 interactions | 3.29e-04 | 70 | 8 | 2 | int:MIR9-3 | |
| Interaction | MIR29B2 interactions | 3.38e-04 | 71 | 8 | 2 | int:MIR29B2 | |
| Interaction | MIR140 interactions | 3.38e-04 | 71 | 8 | 2 | int:MIR140 | |
| Interaction | MIR122 interactions | 3.38e-04 | 71 | 8 | 2 | int:MIR122 | |
| Interaction | MIR29B1 interactions | 3.57e-04 | 73 | 8 | 2 | int:MIR29B1 | |
| Interaction | MIR18A interactions | 3.57e-04 | 73 | 8 | 2 | int:MIR18A | |
| Interaction | MIR20A interactions | 3.67e-04 | 74 | 8 | 2 | int:MIR20A | |
| Interaction | SETD1B interactions | 3.77e-04 | 75 | 8 | 2 | int:SETD1B | |
| Interaction | MIR15A interactions | 3.77e-04 | 75 | 8 | 2 | int:MIR15A | |
| Interaction | MIR429 interactions | 3.87e-04 | 76 | 8 | 2 | int:MIR429 | |
| Interaction | MIR16-1 interactions | 3.87e-04 | 76 | 8 | 2 | int:MIR16-1 | |
| Interaction | MIR7-3 interactions | 3.87e-04 | 76 | 8 | 2 | int:MIR7-3 | |
| Interaction | MIR199A2 interactions | 3.87e-04 | 76 | 8 | 2 | int:MIR199A2 | |
| Interaction | MIR9-2 interactions | 3.97e-04 | 77 | 8 | 2 | int:MIR9-2 | |
| Interaction | MIR200A interactions | 3.97e-04 | 77 | 8 | 2 | int:MIR200A | |
| Interaction | MIR451A interactions | 4.08e-04 | 78 | 8 | 2 | int:MIR451A | |
| Interaction | MIR98 interactions | 4.08e-04 | 78 | 8 | 2 | int:MIR98 | |
| Interaction | MIR92A1 interactions | 4.08e-04 | 78 | 8 | 2 | int:MIR92A1 | |
| Interaction | MIR222 interactions | 4.18e-04 | 79 | 8 | 2 | int:MIR222 | |
| Interaction | MIR206 interactions | 4.18e-04 | 79 | 8 | 2 | int:MIR206 | |
| Interaction | MIR34C interactions | 4.18e-04 | 79 | 8 | 2 | int:MIR34C | |
| Interaction | MIR1-2 interactions | 4.18e-04 | 79 | 8 | 2 | int:MIR1-2 | |
| Interaction | MIR143 interactions | 4.29e-04 | 80 | 8 | 2 | int:MIR143 | |
| Interaction | MIR145 interactions | 4.40e-04 | 81 | 8 | 2 | int:MIR145 | |
| Interaction | MIR10B interactions | 4.51e-04 | 82 | 8 | 2 | int:MIR10B | |
| Interaction | MIR106A interactions | 4.62e-04 | 83 | 8 | 2 | int:MIR106A | |
| Interaction | MIR200B interactions | 4.73e-04 | 84 | 8 | 2 | int:MIR200B | |
| Interaction | MIR7-2 interactions | 4.73e-04 | 84 | 8 | 2 | int:MIR7-2 | |
| Interaction | MIR31 interactions | 4.73e-04 | 84 | 8 | 2 | int:MIR31 | |
| Interaction | MIR199A1 interactions | 4.73e-04 | 84 | 8 | 2 | int:MIR199A1 | |
| Interaction | MIR16-2 interactions | 4.84e-04 | 85 | 8 | 2 | int:MIR16-2 | |
| Interaction | MIR93 interactions | 4.84e-04 | 85 | 8 | 2 | int:MIR93 | |
| Interaction | MIR9-1 interactions | 4.84e-04 | 85 | 8 | 2 | int:MIR9-1 | |
| Interaction | MIR107 interactions | 4.84e-04 | 85 | 8 | 2 | int:MIR107 | |
| Interaction | MIR17 interactions | 4.84e-04 | 85 | 8 | 2 | int:MIR17 | |
| Interaction | MIR18B interactions | 4.84e-04 | 85 | 8 | 2 | int:MIR18B | |
| Interaction | MIR20B interactions | 4.96e-04 | 86 | 8 | 2 | int:MIR20B | |
| Interaction | MIR29A interactions | 5.07e-04 | 87 | 8 | 2 | int:MIR29A | |
| Interaction | MIR141 interactions | 5.19e-04 | 88 | 8 | 2 | int:MIR141 | |
| Interaction | MIR138-2 interactions | 5.19e-04 | 88 | 8 | 2 | int:MIR138-2 | |
| Interaction | MIR29C interactions | 5.31e-04 | 89 | 8 | 2 | int:MIR29C | |
| Interaction | MIR221 interactions | 5.43e-04 | 90 | 8 | 2 | int:MIR221 | |
| Interaction | MIR92A2 interactions | 5.43e-04 | 90 | 8 | 2 | int:MIR92A2 | |
| Interaction | MIR1-1 interactions | 5.43e-04 | 90 | 8 | 2 | int:MIR1-1 | |
| Interaction | MIR200C interactions | 5.55e-04 | 91 | 8 | 2 | int:MIR200C | |
| Interaction | MIR128-1 interactions | 5.67e-04 | 92 | 8 | 2 | int:MIR128-1 | |
| Interaction | MIR155 interactions | 5.67e-04 | 92 | 8 | 2 | int:MIR155 | |
| Interaction | MIR214 interactions | 5.79e-04 | 93 | 8 | 2 | int:MIR214 | |
| Interaction | MIR205 interactions | 5.79e-04 | 93 | 8 | 2 | int:MIR205 | |
| Interaction | MIR19B2 interactions | 5.92e-04 | 94 | 8 | 2 | int:MIR19B2 | |
| Interaction | KHDRBS3 interactions | 5.92e-04 | 94 | 8 | 2 | int:KHDRBS3 | |
| Interaction | MIRLET7F1 interactions | 5.92e-04 | 94 | 8 | 2 | int:MIRLET7F1 | |
| Interaction | PLXNA3 interactions | 6.17e-04 | 96 | 8 | 2 | int:PLXNA3 | |
| Interaction | MIRLET7A2 interactions | 6.17e-04 | 96 | 8 | 2 | int:MIRLET7A2 | |
| Interaction | MIRLET7C interactions | 6.30e-04 | 97 | 8 | 2 | int:MIRLET7C | |
| Interaction | MIR21 interactions | 6.30e-04 | 97 | 8 | 2 | int:MIR21 | |
| Interaction | MIRLET7F2 interactions | 6.30e-04 | 97 | 8 | 2 | int:MIRLET7F2 | |
| Interaction | MIR363 interactions | 6.30e-04 | 97 | 8 | 2 | int:MIR363 | |
| Interaction | MIR106B interactions | 6.43e-04 | 98 | 8 | 2 | int:MIR106B | |
| Interaction | MIR128-2 interactions | 6.56e-04 | 99 | 8 | 2 | int:MIR128-2 | |
| Interaction | MIR19A interactions | 6.69e-04 | 100 | 8 | 2 | int:MIR19A | |
| Interaction | MIRLET7B interactions | 6.83e-04 | 101 | 8 | 2 | int:MIRLET7B | |
| Interaction | MIRLET7D interactions | 6.83e-04 | 101 | 8 | 2 | int:MIRLET7D | |
| Interaction | MIR25 interactions | 6.83e-04 | 101 | 8 | 2 | int:MIR25 | |
| Interaction | MIRLET7A3 interactions | 6.96e-04 | 102 | 8 | 2 | int:MIRLET7A3 | |
| Interaction | MIR7-1 interactions | 7.10e-04 | 103 | 8 | 2 | int:MIR7-1 | |
| Interaction | MIR15B interactions | 7.10e-04 | 103 | 8 | 2 | int:MIR15B | |
| Interaction | PRMT8 interactions | 7.24e-04 | 104 | 8 | 2 | int:PRMT8 | |
| Interaction | MIR34A interactions | 7.24e-04 | 104 | 8 | 2 | int:MIR34A | |
| Interaction | MIR19B1 interactions | 7.24e-04 | 104 | 8 | 2 | int:MIR19B1 | |
| Interaction | MIRLET7E interactions | 7.52e-04 | 106 | 8 | 2 | int:MIRLET7E | |
| Interaction | MIRLET7A1 interactions | 7.80e-04 | 108 | 8 | 2 | int:MIRLET7A1 | |
| Interaction | MIR34B interactions | 8.09e-04 | 110 | 8 | 2 | int:MIR34B | |
| Interaction | EPRS1 interactions | 8.35e-04 | 513 | 8 | 3 | int:EPRS1 | |
| Interaction | SMN2 interactions | 8.69e-04 | 114 | 8 | 2 | int:SMN2 | |
| Interaction | MIRLET7I interactions | 8.69e-04 | 114 | 8 | 2 | int:MIRLET7I | |
| Interaction | USP13 interactions | 8.69e-04 | 114 | 8 | 2 | int:USP13 | |
| Interaction | MIRLET7G interactions | 9.15e-04 | 117 | 8 | 2 | int:MIRLET7G | |
| Interaction | SCARNA22 interactions | 9.30e-04 | 118 | 8 | 2 | int:SCARNA22 | |
| Interaction | KHDRBS2 interactions | 1.11e-03 | 129 | 8 | 2 | int:KHDRBS2 | |
| Interaction | UBE2S interactions | 1.27e-03 | 138 | 8 | 2 | int:UBE2S | |
| Interaction | ACSL4 interactions | 1.31e-03 | 140 | 8 | 2 | int:ACSL4 | |
| Interaction | IL7R interactions | 1.32e-03 | 141 | 8 | 2 | int:IL7R | |
| Interaction | DAZL interactions | 1.40e-03 | 145 | 8 | 2 | int:DAZL | |
| Interaction | CPEB1 interactions | 1.42e-03 | 146 | 8 | 2 | int:CPEB1 | |
| Interaction | APOBEC3D interactions | 1.46e-03 | 148 | 8 | 2 | int:APOBEC3D | |
| Interaction | MORF4L2 interactions | 1.87e-03 | 168 | 8 | 2 | int:MORF4L2 | |
| Interaction | TOP1 interactions | 2.02e-03 | 696 | 8 | 3 | int:TOP1 | |
| Interaction | H2BC1 interactions | 2.10e-03 | 178 | 8 | 2 | int:H2BC1 | |
| GeneFamily | Collagens | 1.76e-04 | 46 | 8 | 2 | 490 | |
| GeneFamily | Actins|Deafness associated genes | 1.06e-03 | 113 | 8 | 2 | 1152 | |
| GeneFamily | RNA binding motif containing | 3.69e-03 | 213 | 8 | 2 | 725 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 1.24e-05 | 18 | 8 | 2 | M47984 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 3.30e-05 | 29 | 8 | 2 | MM17055 | |
| Coexpression | BUSSLINGER_GASTRIC_NECK_CELLS | 5.11e-05 | 36 | 8 | 2 | M40008 | |
| Coexpression | NABA_CORE_MATRISOME | 5.83e-05 | 270 | 8 | 3 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 6.15e-05 | 275 | 8 | 3 | M5884 | |
| Coexpression | ELLWOOD_MYC_TARGETS_DN | 6.98e-05 | 42 | 8 | 2 | MM814 | |
| Coexpression | NABA_COLLAGENS | 7.31e-05 | 43 | 8 | 2 | MM17060 | |
| Coexpression | ELLWOOD_MYC_TARGETS_DN | 7.31e-05 | 43 | 8 | 2 | M6951 | |
| Coexpression | NABA_COLLAGENS | 7.66e-05 | 44 | 8 | 2 | M3005 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 1.16e-04 | 54 | 8 | 2 | MM927 | |
| Coexpression | IKEDA_MIR1_TARGETS_UP | 1.16e-04 | 54 | 8 | 2 | M2372 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 1.38e-04 | 59 | 8 | 2 | M47993 | |
| Coexpression | LIU_COMMON_CANCER_GENES | 1.58e-04 | 63 | 8 | 2 | M18694 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS | 2.48e-04 | 79 | 8 | 2 | M40003 | |
| Coexpression | MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP | 3.01e-04 | 87 | 8 | 2 | M945 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 3.29e-04 | 91 | 8 | 2 | M40180 | |
| Coexpression | CAHOY_ASTROGLIAL | 3.98e-04 | 100 | 8 | 2 | M2807 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 5.72e-04 | 120 | 8 | 2 | M42505 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 7.44e-04 | 137 | 8 | 2 | M40313 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 8.87e-04 | 681 | 8 | 3 | M39175 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 1.35e-03 | 185 | 8 | 2 | M42503 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 1.45e-03 | 192 | 8 | 2 | M42501 | |
| Coexpression | GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN | 1.45e-03 | 192 | 8 | 2 | M7571 | |
| Coexpression | GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP | 1.48e-03 | 194 | 8 | 2 | M7288 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN | 1.56e-03 | 199 | 8 | 2 | M5707 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_DN | 1.56e-03 | 199 | 8 | 2 | M9890 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP | 1.56e-03 | 199 | 8 | 2 | M8107 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN | 1.57e-03 | 200 | 8 | 2 | M7771 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN | 1.57e-03 | 200 | 8 | 2 | M6617 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.57e-03 | 200 | 8 | 2 | M5930 | |
| Coexpression | HALLMARK_MYC_TARGETS_V1 | 1.57e-03 | 200 | 8 | 2 | M5926 | |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP | 1.57e-03 | 200 | 8 | 2 | M6307 | |
| Coexpression | GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN | 1.57e-03 | 200 | 8 | 2 | M9628 | |
| Coexpression | RAO_BOUND_BY_SALL4 | 2.00e-03 | 226 | 8 | 2 | M2521 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 3.96e-06 | 188 | 8 | 3 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 198 | 8 | 3 | d3a475be01657a03fcbb0ee0a246b1e90deacaa4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 198 | 8 | 3 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | droplet-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-06 | 198 | 8 | 3 | 985022c1722ab7b67675ebe814022a439e715b5e | |
| ToppCell | droplet-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.63e-06 | 198 | 8 | 3 | 1beed34f469aad07e8f674f0b668d6e1e916403c | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.55e-04 | 107 | 8 | 2 | 60b272f5c89bea8a2714f870e18b7ac89a4a4bf6 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.55e-04 | 107 | 8 | 2 | c41bc8810df67158f0ae9f6015c965a8ebd96965 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn-Endothelial_Tip.Dcn.Nenf_(Nenf)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.76e-04 | 114 | 8 | 2 | 7be16e7f7b9c9dbd68933ace3b7f8f661bed41a7 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Dcn|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.76e-04 | 114 | 8 | 2 | f4bdfc47418d22a49e0c4a6c3bd0663e15fb53bb | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.44e-04 | 134 | 8 | 2 | a3547a68012d879d4dfe80394eace70808722e43 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.44e-04 | 134 | 8 | 2 | 9458e2d0dbc18d9025b66b59f3ecc2fbc5384940 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.51e-04 | 136 | 8 | 2 | 3e13dc0634f3b05e9f9e6c3193f843f62e603b78 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.51e-04 | 136 | 8 | 2 | 0185486c39700dd2f72d79be6d283494dd8379c9 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.58e-04 | 138 | 8 | 2 | 76be06136c83c167cedece7515228ed4d29dd1f0 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 2.93e-04 | 147 | 8 | 2 | 87c24843cb0e87ad42e725d08423131a5d2d25a3 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.01e-04 | 149 | 8 | 2 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.17e-04 | 153 | 8 | 2 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.17e-04 | 153 | 8 | 2 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.17e-04 | 153 | 8 | 2 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 3.17e-04 | 153 | 8 | 2 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.17e-04 | 153 | 8 | 2 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD8-Trm_gut_CD8|bone_marrow / Manually curated celltypes from each tissue | 3.22e-04 | 154 | 8 | 2 | 93145a1bc5712ae664690b03a9e00ce1f92cfc7e | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.34e-04 | 157 | 8 | 2 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage-interstitial_macrophage_l12|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.38e-04 | 158 | 8 | 2 | 2438713d2a7e32c647ab3384237ed614f4ec8fec | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic-CD141-positive_myeloid_dendritic_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.38e-04 | 158 | 8 | 2 | 4f3ea658e032555c2098d016475381c8d1071699 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-interstitial_macrophage|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.38e-04 | 158 | 8 | 2 | 9a6d9b541446a6aa9f8ed040b330dbb5c6447076 | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 3.47e-04 | 160 | 8 | 2 | ab769516f9f7798d1390ef215caf22a2d3d53e63 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-04 | 160 | 8 | 2 | c1d03c0ac9c12615a06499209fcdf18e9b6f1fba | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|(1)_Control_(PBS) / Stress and Cell class | 3.47e-04 | 160 | 8 | 2 | 8450466fc2465c56798df2b520edd23c2c2e941c | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.47e-04 | 160 | 8 | 2 | 41d6c811c445c0ba9b6a2deb10a3b6b793172582 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 161 | 8 | 2 | 110cc7122e3c9f105a11d811d77c8a8852b9de6c | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 161 | 8 | 2 | f1d3287d9cb4e0eec99b3509f5dc4b87ae8c8cc9 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_dendritic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.56e-04 | 162 | 8 | 2 | 233011408f022647932c81ebab78f9813e3c6833 | |
| ToppCell | 10x5'-Liver-Lymphocytic_Invariant-Inducer-like-ILC3|Liver / Manually curated celltypes from each tissue | 3.60e-04 | 163 | 8 | 2 | 7f61483eeb1fde21843c6391468e13cb0cc2a89f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.73e-04 | 166 | 8 | 2 | 81c546c6d847e49e662b81e71992ca0f7a99e890 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.73e-04 | 166 | 8 | 2 | 37794a84601a2a949d579663d4a4bb8bc8fb5923 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-04 | 167 | 8 | 2 | 3ad9f3122dbe96580f640388ef920ea209fc2349 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-04 | 167 | 8 | 2 | 3e3d8f6df2feefafad5b44ba0ebf5b5a0fe4ed58 | |
| ToppCell | facs-Trachea-nan-18m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-04 | 167 | 8 | 2 | 7b1fd19946cee67dae68f0f0d98420abcd532482 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.78e-04 | 167 | 8 | 2 | 102b3d160a44c8623fab1fd10e9054178c42a78b | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-04 | 168 | 8 | 2 | 838ce47d4958ba12047882f97925eddd02f081c7 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.82e-04 | 168 | 8 | 2 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-H-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.82e-04 | 168 | 8 | 2 | b5d74500bdac0d680ce7eb7afa0b867b8d85e6a4 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.82e-04 | 168 | 8 | 2 | ca94b29c1030484143a77f2df06dad74d2c6136e | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.87e-04 | 169 | 8 | 2 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.92e-04 | 170 | 8 | 2 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.96e-04 | 171 | 8 | 2 | d2938639e9a7c349e5a6ec61724222f9d127c89f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.01e-04 | 172 | 8 | 2 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | (0)_Normal/No_Treatment-(4)_COL2.3+_osteoblasts|(0)_Normal/No_Treatment / Stress and Cell class | 4.05e-04 | 173 | 8 | 2 | c2a0f674681836b5a868c13f67caa7d555ef6519 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-chondrocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.05e-04 | 173 | 8 | 2 | 2226505610af1becc253d0a5550627144ef0ed6b | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 4.10e-04 | 174 | 8 | 2 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | 10x5'-blood-Lymphocytic_Invariant-Inducer-like|blood / Manually curated celltypes from each tissue | 4.10e-04 | 174 | 8 | 2 | 51be6f29308c01593978cbee92114151a5916c9c | |
| ToppCell | Basal_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 4.10e-04 | 174 | 8 | 2 | a0060be3940043015dcc49a5157de5541aed24a1 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.15e-04 | 175 | 8 | 2 | f1394aacc8a94ca555dd19aaed5a18da99c6bf40 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.15e-04 | 175 | 8 | 2 | 7bf1194d93fbe2dbf9d953e0a32b2a6d88251ed1 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.15e-04 | 175 | 8 | 2 | 085cceb1fc2c4ae2f27e85cea5702defecc2cf44 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.20e-04 | 176 | 8 | 2 | 77c3da2eaa072a6baefb5087fd07ec18c5e271cd | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.20e-04 | 176 | 8 | 2 | 2015539c58aa0bb118e111ffedd63dd9fe863bb1 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.20e-04 | 176 | 8 | 2 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.24e-04 | 177 | 8 | 2 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-chondrocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.24e-04 | 177 | 8 | 2 | 915b848d789051a1c3bc6f6dc86955bb752276ab | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.24e-04 | 177 | 8 | 2 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-8|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.24e-04 | 177 | 8 | 2 | 066e7500e7bdde88a7914f50a4661d8adf6db925 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-04 | 178 | 8 | 2 | e5e5f5b4a27e120a1076b1cb250fa25d0c336956 | |
| ToppCell | (5)_Glands_mucous|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.29e-04 | 178 | 8 | 2 | f0f19b0d78f2cc5df4d4c321a953a6e447d5114a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.29e-04 | 178 | 8 | 2 | c661246269ce26c4fc62e12f86c5f90a2dcfdce0 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.29e-04 | 178 | 8 | 2 | 8591a40fced747ac16b3e8ebc7a22dfb3ad76da2 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Mucous|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.34e-04 | 179 | 8 | 2 | 9caa7903950c806921b1036103ad0d332a441253 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Mucous-Mucous|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.34e-04 | 179 | 8 | 2 | dc4d1b3f63df2c657fea51da011488ee724ee1bf | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-04 | 180 | 8 | 2 | c2746092ef251e9d5910fe96461afdd0624a24c6 | |
| ToppCell | Mesenchymal_cells-Chondrocytes|Mesenchymal_cells / Lineage and Cell class | 4.39e-04 | 180 | 8 | 2 | 6e399368430ef3afa9ce1ef0ed90f614ccef9987 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.39e-04 | 180 | 8 | 2 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.39e-04 | 180 | 8 | 2 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-04 | 180 | 8 | 2 | 32c6a3886428d82fb4355d987c6d2645f333447b | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 4.44e-04 | 181 | 8 | 2 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|(2)_5-FU / Stress and Cell class | 4.44e-04 | 181 | 8 | 2 | 56ae86072858c156681507aecd1bc6cb0a3372d2 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-04 | 181 | 8 | 2 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.44e-04 | 181 | 8 | 2 | c26d3cbbc592299786d79d1b15fc6bead2aafb9a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.44e-04 | 181 | 8 | 2 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.44e-04 | 181 | 8 | 2 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.48e-04 | 182 | 8 | 2 | 724c33ad2fb525cbcfa5efa3362675eb42a5636d | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.48e-04 | 182 | 8 | 2 | 88bd17c07bd8443a0ede4e9dc7bc9d1230b42211 | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.48e-04 | 182 | 8 | 2 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.48e-04 | 182 | 8 | 2 | 193cb2df3d7ea4cb9a11390b92955e7d9b0a053a | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.48e-04 | 182 | 8 | 2 | ba066ff9029cc052b76e2330ec168cb2e9b7e498 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular-Chondrocyte|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.48e-04 | 182 | 8 | 2 | 507f095af4dff60f2c2b64d750477154084c3595 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.48e-04 | 182 | 8 | 2 | 00a148b1e499bf16325491536d187d4dd6b70c06 | |
| ToppCell | cellseq-Mesenchymal-Chondrocytic-Mesenchymal_Airway/Vascular|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.48e-04 | 182 | 8 | 2 | bb7de0c93d8f59f13c990e425139b9348ca8027e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_osteo-stroma-chondrocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.48e-04 | 182 | 8 | 2 | ed487f3a774812caa2903a646b60c86edcc1e65e | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.48e-04 | 182 | 8 | 2 | e9fcae9d03a6faf85b91882c5da699037bc61aeb | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 4.58e-04 | 184 | 8 | 2 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | Mesenchymal_cells-Chondrocytes|World / Lineage and Cell class | 4.58e-04 | 184 | 8 | 2 | 1e03f9f08de5ad4d45388a95afad9f23ff0d0e28 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.63e-04 | 185 | 8 | 2 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.63e-04 | 185 | 8 | 2 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 185 | 8 | 2 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.63e-04 | 185 | 8 | 2 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.63e-04 | 185 | 8 | 2 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-4|TCGA-Bladder / Sample_Type by Project: Shred V9 | 4.63e-04 | 185 | 8 | 2 | e1f3f0e974eb3fe1c05018beb9e124c7fb0cbe50 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 185 | 8 | 2 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 4.68e-04 | 186 | 8 | 2 | 80a0a42ca8585cdb1dda57a18c254316a126ee64 | |
| Computational | Neighborhood of DENR | 6.07e-04 | 51 | 8 | 2 | GNF2_DENR | |
| Computational | Neighborhood of SMC1L1 | 8.96e-04 | 62 | 8 | 2 | MORF_SMC1L1 | |
| Computational | Neighborhood of KPNB1 | 1.24e-03 | 73 | 8 | 2 | GNF2_KPNB1 | |
| Computational | Neighborhood of APEX1 | 1.96e-03 | 92 | 8 | 2 | GNF2_APEX1 | |
| Drug | 351A | 2.05e-05 | 20 | 8 | 2 | CID000122144 | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.41e-05 | 196 | 8 | 3 | 1524_DN | |
| Drug | rotenone; Down 200; 1uM; MCF7; HT_HG-U133A | 3.51e-05 | 198 | 8 | 3 | 5943_DN | |
| Drug | dermatan sulfate | 4.81e-05 | 220 | 8 | 3 | CID000032756 | |
| Drug | isodesmosine | 5.67e-05 | 33 | 8 | 2 | CID000013811 | |
| Drug | Sirius red | 6.39e-05 | 35 | 8 | 2 | CID005486818 | |
| Drug | GK-101 | 6.77e-05 | 36 | 8 | 2 | CID000161853 | |
| Drug | AC1MRIIV | 7.95e-05 | 39 | 8 | 2 | CID003518584 | |
| Drug | PD123177 | 9.69e-05 | 43 | 8 | 2 | CID000114899 | |
| Drug | NC-4 | 1.01e-04 | 44 | 8 | 2 | CID006420119 | |
| Drug | 1zd2 | 1.06e-04 | 45 | 8 | 2 | CID004149241 | |
| Drug | Madecassol | 1.11e-04 | 46 | 8 | 2 | CID000108062 | |
| Drug | d-indobufen | 1.31e-04 | 50 | 8 | 2 | CID000044562 | |
| Drug | formycin triphosphate | 1.37e-04 | 51 | 8 | 2 | CID000122274 | |
| Drug | ridogrel | 1.42e-04 | 52 | 8 | 2 | CID005362391 | |
| Drug | desmosine | 1.48e-04 | 53 | 8 | 2 | CID000025435 | |
| Drug | NSC49633 | 1.48e-04 | 53 | 8 | 2 | CID000023340 | |
| Drug | 1h00 | 1.65e-04 | 56 | 8 | 2 | CID000445950 | |
| Drug | trapidil | 1.71e-04 | 57 | 8 | 2 | CID000005531 | |
| Drug | AC1Q641C | 2.02e-04 | 62 | 8 | 2 | CID000005005 | |
| Drug | AC1LAKND | 2.02e-04 | 62 | 8 | 2 | CID000470146 | |
| Drug | BAPN | 2.65e-04 | 71 | 8 | 2 | CID000001647 | |
| Drug | malotilate | 2.65e-04 | 71 | 8 | 2 | CID000004006 | |
| Drug | AC1NMZ1B | 2.96e-04 | 75 | 8 | 2 | CID005034185 | |
| Drug | chondroitin sulfate | 3.10e-04 | 413 | 8 | 3 | CID000024766 | |
| Drug | strontium ranelate | 3.12e-04 | 77 | 8 | 2 | CID006918182 | |
| Drug | homocystine | 3.54e-04 | 82 | 8 | 2 | CID000010010 | |
| Drug | halofuginone lactate | 3.80e-04 | 85 | 8 | 2 | CID000062891 | |
| Drug | 4-hydroxyproline | 4.36e-04 | 91 | 8 | 2 | CID000000825 | |
| Drug | AC1L9HPX | 4.45e-04 | 92 | 8 | 2 | CID000445279 | |
| Drug | AC1L1KMJ | 4.70e-04 | 476 | 8 | 3 | CID000030956 | |
| Drug | pyridinoline | 5.15e-04 | 99 | 8 | 2 | CID000105068 | |
| Drug | ethylnylestradiol | 5.31e-04 | 1251 | 8 | 4 | CID000003285 | |
| Drug | ticlopidine | 5.58e-04 | 103 | 8 | 2 | CID000005472 | |
| Drug | hydroxylysine | 6.24e-04 | 109 | 8 | 2 | CID000001029 | |
| Drug | AC1L1C2F | 6.35e-04 | 110 | 8 | 2 | CID000001711 | |
| Drug | PPACK | 6.70e-04 | 113 | 8 | 2 | CID003036757 | |
| Drug | AC1L9732 | 6.82e-04 | 114 | 8 | 2 | CID000439300 | |
| Drug | Tranilast sodium | 6.94e-04 | 115 | 8 | 2 | CID000005527 | |
| Drug | testosterone enanthate | 8.16e-04 | 575 | 8 | 3 | ctd:C004648 | |
| Drug | Selara | 8.19e-04 | 125 | 8 | 2 | CID000150310 | |
| Drug | bromovanin | 8.46e-04 | 127 | 8 | 2 | ctd:C515564 | |
| Drug | AC1OCADI | 8.86e-04 | 130 | 8 | 2 | CID006914639 | |
| Drug | DMSe | 9.13e-04 | 132 | 8 | 2 | CID000020796 | |
| Drug | pirfenidone | 9.97e-04 | 138 | 8 | 2 | CID000040632 | |
| Drug | PCR 4099 | 1.01e-03 | 139 | 8 | 2 | CID000002806 | |
| Drug | DL-penicillamine | 1.01e-03 | 139 | 8 | 2 | CID000004727 | |
| Drug | candesartan cilexetil | 1.10e-03 | 145 | 8 | 2 | CID000002540 | |
| Drug | calcium phosphate | 1.16e-03 | 149 | 8 | 2 | CID000024441 | |
| Drug | AC1L1AUZ | 1.29e-03 | 157 | 8 | 2 | CID000001160 | |
| Drug | L-lysyl-L-lysyl-L-lysine | 1.37e-03 | 162 | 8 | 2 | CID000072363 | |
| Drug | diphenylamine-2-carboxylate | 1.40e-03 | 164 | 8 | 2 | CID000004386 | |
| Drug | khellin | 1.52e-03 | 171 | 8 | 2 | CID000003828 | |
| Drug | AC1NRA5C | 1.58e-03 | 174 | 8 | 2 | CID005287709 | |
| Drug | AC1L1DD6 | 1.67e-03 | 179 | 8 | 2 | CID000002299 | |
| Drug | fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A | 1.80e-03 | 186 | 8 | 2 | 6996_UP | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 1.86e-03 | 189 | 8 | 2 | CID000001413 | |
| Drug | foscarnet | 1.88e-03 | 190 | 8 | 2 | CID000003414 | |
| Drug | estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 1.92e-03 | 192 | 8 | 2 | 5955_UP | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 1.92e-03 | 192 | 8 | 2 | 6054_DN | |
| Drug | LY 294002; Down 200; 10uM; PC3; HT_HG-U133A | 1.94e-03 | 193 | 8 | 2 | 1236_DN | |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 3859_DN | |
| Drug | Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.96e-03 | 194 | 8 | 2 | 2284_DN | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 2621_DN | |
| Drug | Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 7468_UP | |
| Drug | Carbimazole [22232-54-8]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 5399_DN | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 4199_DN | |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 6098_DN | |
| Drug | Cephalothin sodium salt [58-71-9]; Up 200; 9.6uM; HL60; HT_HG-U133A | 1.98e-03 | 195 | 8 | 2 | 2517_UP | |
| Drug | Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; PC3; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 6754_UP | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 2.00e-03 | 196 | 8 | 2 | 3410_UP | |
| Drug | R(+)-verapamil hydrochloride; Up 200; 10uM; MCF7; HG-U133A | 2.00e-03 | 196 | 8 | 2 | 164_UP | |
| Drug | Troleandomycin [2751-09-9]; Up 200; 5uM; PC3; HG-U133A | 2.02e-03 | 197 | 8 | 2 | 1885_UP | |
| Drug | Enalapril maleate [76095-16-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 7026_DN | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 5447_UP | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; PC3; HG-U133A | 2.02e-03 | 197 | 8 | 2 | 1925_UP | |
| Drug | Vitamin K2 [11032-49-8]; Down 200; 9uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3798_DN | |
| Drug | Midecamycin [35457-80-8]; Up 200; 5uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 6745_UP | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3870_DN | |
| Drug | Mimosine [500-44-7]; Down 200; 20.2uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 2638_DN | |
| Drug | 0175029-0000 [211245-78-2]; Down 200; 1uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 3694_DN | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 4277_DN | |
| Drug | Todralazine hydrochloride [3778-76-5]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 1677_UP | |
| Drug | Penbutolol sulfate [38363-32-5]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 7476_UP | |
| Drug | Lobelanidine hydrochloride [6112-86-3]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.02e-03 | 197 | 8 | 2 | 5500_DN | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 5475_DN | |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.04e-03 | 198 | 8 | 2 | 7544_UP | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 8.15e-05 | 51 | 8 | 2 | cv:CN043650 | |
| Disease | Nonsyndromic genetic hearing loss | 1.81e-04 | 76 | 8 | 2 | cv:C5680182 | |
| Disease | Nonsyndromic Deafness | 2.06e-04 | 81 | 8 | 2 | C3711374 | |
| Disease | hearing impairment | 3.02e-04 | 98 | 8 | 2 | C1384666 | |
| Disease | Hereditary hearing loss and deafness | 6.68e-04 | 146 | 8 | 2 | cv:C0236038 | |
| Disease | Prostatic Neoplasms | 1.12e-02 | 616 | 8 | 2 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.12e-02 | 616 | 8 | 2 | C0376358 | |
| Disease | Abnormality of refraction | 1.33e-02 | 673 | 8 | 2 | HP_0000539 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| STYYDPYDPYPYETY | 36 | Q06828 | |
| PYDPYPYETYEPYPY | 41 | Q06828 | |
| DHYYGYPPEDPYDYY | 276 | Q9UKN7 | |
| YPPEDPYDYYHPDYY | 281 | Q9UKN7 | |
| YPPDYYGYEDYYDYY | 456 | O60506 | |
| PPDYYGYEDYYDDYY | 461 | O43390 | |
| QPTESLYYDYEPPYY | 266 | P13942 | |
| ETYYYEYPYYEDPED | 271 | P20908 | |
| VSVYNSYPYYPYLYC | 211 | Q99801 | |
| YYHSYDPYYSPSYMH | 996 | Q9ULD9 |